ArticleBMC cancer2024

Prolonged 14-day continuous infusion of high-dose ifosfamide for patients with relapsed and refractory high-grade osteosarcoma: a retrospective multicentre cohort study.

Elisa Tirtei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.